{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:25:14Z","timestamp":1793993114520,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ebiom.2020.102731","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T17:15:37Z","timestamp":1588007737000},"page":"102731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab"],"prefix":"10.1016","volume":"54","author":[{"given":"Yuankai","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ebiom.2020.102731_bib0001","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3109\/10428194.2010.525724","article-title":"Comparing adult and pediatric Hodgkin lymphoma in the surveillance, epidemiology and end results program, 1988-2005: an analysis of 21 734 cases","volume":"51","author":"Bazzeh","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102731_bib0002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12185-018-2404-8","article-title":"Current status and progress of lymphoma management in China","volume":"107","author":"Shi","year":"2018","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102731_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin's lymphoma","volume":"9","author":"Kuppers","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102731_bib0004","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ajh.25071","article-title":"Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management","volume":"93","author":"Ansell","year":"2018","journal-title":"Am J Hematol."},{"issue":"9","key":"10.1016\/j.ebiom.2020.102731_bib0005","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S1470-2045(16)30167-X","article-title":"Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial","volume":"17","author":"Younes","year":"2016","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.ebiom.2020.102731_bib0006","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","article-title":"Phase ii study of the efficacy and safety of pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma","volume":"35","author":"Chen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ebiom.2020.102731_bib0007","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","article-title":"PD-L1 and PD-L2 genetic alterations define classical hodgkin lymphoma and predict outcome","volume":"34","author":"Roemer","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102731_bib0008","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102731_bib0009","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/1078-0432.CCR-17-1341","article-title":"Early assessment of lung cancer immunotherapy response via circulating tumor dna","volume":"24","author":"Goldberg","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"28","key":"10.1016\/j.ebiom.2020.102731_bib0010","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating tumor dna measurements as early outcome predictors in diffuse large B-Cell lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102731_bib0011","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3324\/haematol.2016.145102","article-title":"Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma","volume":"101","author":"Camus","year":"2016","journal-title":"Haematologica"},{"issue":"22","key":"10.1016\/j.ebiom.2020.102731_bib0012","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102731_bib0013","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S2352-3026(18)30192-3","article-title":"Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial","volume":"6","author":"Shi","year":"2019","journal-title":"Lancet Haematol"},{"issue":"14","key":"10.1016\/j.ebiom.2020.102731_bib0014","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102731_bib0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmoldx.2017.04.007","article-title":"Technical validation of a next-generation sequencing assay for detecting clinically relevant levels of breast cancer-related single-nucleotide variants and copy number variants using simulated cell-free dna","volume":"19","author":"Yang","year":"2017","journal-title":"J Mol Diagn"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102731_bib0016","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102731_bib0017","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a mapreduce framework for analyzing next-generation dna sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102731_bib0018","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/bioinformatics\/bts146","article-title":"CONTRA: copy number analysis for targeted resequencing","volume":"28","author":"Li","year":"2012","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102731_bib0019","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: statistical inference of clonal population structure in cancer","volume":"11","author":"Roth","year":"2014","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102731_bib0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102731_bib0021","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102731_bib0022","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2352-3026(14)00039-8","article-title":"Non-invasive detection of genomic imbalances in Hodgkin\/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study","volume":"2","author":"Vandenberghe","year":"2015","journal-title":"Lancet Haematol"},{"issue":"364","key":"10.1016\/j.ebiom.2020.102731_bib0023","doi-asserted-by":"crossref","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102731_bib0024","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12185-018-2487-2","article-title":"Circulating tumor DNA dynamically predicts response and\/or relapse in patients with hematological malignancies","volume":"108","author":"Nakamura","year":"2018","journal-title":"Int J Hematol"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102731_bib0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102731_bib0026","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ncb1831","article-title":"CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis","volume":"11","author":"Nishiyama","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102731_bib0027","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2217\/imt-2018-0084","article-title":"Monitoring immunotherapy outcomes with circulating tumor DNA","volume":"10","author":"Goldberg","year":"2018","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102731_bib0028","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102731_bib0029","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1158\/1078-0432.CCR-16-1946","article-title":"Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition","volume":"23","author":"Pereira","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.ebiom.2020.102731_bib0030","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-16-0008","article-title":"Melanoma lesions independently acquire T-cell resistance during metastatic latency","volume":"76","author":"Zhao","year":"2016","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102731_bib0031","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.immuni.2017.02.001","article-title":"Loss of pten is associated with resistance to anti-pd-1 checkpoint blockade therapy in metastatic uterine leiomyosarcoma","volume":"46","author":"George","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102731_bib0032","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nat Commun"},{"issue":"10154","key":"10.1016\/j.ebiom.2020.102731_bib0033","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0140-6736(18)31867-1","article-title":"Checkpoint blockade therapy resistance in Hodgkin's lymphoma","volume":"392","author":"Carbone","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102731_bib0034","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1038\/sj.leu.2403175","article-title":"Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase fas-induced apoptosis and improve tumor immunogenicity","volume":"17","author":"Costello","year":"2003","journal-title":"Leukemia"},{"issue":"42","key":"10.1016\/j.ebiom.2020.102731_bib0035","doi-asserted-by":"crossref","first-page":"27548","DOI":"10.1074\/jbc.273.42.27548","article-title":"Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM\/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth","volume":"273","author":"Harrop","year":"1998","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.ebiom.2020.102731_bib0036","doi-asserted-by":"crossref","first-page":"37091","DOI":"10.18632\/oncotarget.16181","article-title":"Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells","volume":"8","author":"Galbiati","year":"2017","journal-title":"Oncotarget"},{"issue":"7167","key":"10.1016\/j.ebiom.2020.102731_bib0037","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature06255","article-title":"JHDM1B\/FBXL10 is a nucleolar protein that represses transcription of ribosomal rna genes","volume":"450","author":"Frescas","year":"2007","journal-title":"Nature"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:57:44Z","timestamp":1762455464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420301067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":37,"alternative-id":["S2352396420301067"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102731","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102731"}}